Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Perspective Therapeutics, Inc. (CATX) vs TriSalus Life Sciences, Inc. (TLSI)

Perspective Therapeutics, Inc. and TriSalus Life Sciences, Inc. are both Medical Devices companies. Perspective Therapeutics, Inc. and TriSalus Life Sciences, Inc. are of similar size ($303.6M and $285.4M). TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against −66.9%. TriSalus Life Sciences, Inc. has the higher net margin (−127.0% vs −28,468.0%) and the higher return on invested capital (0.00% vs −88.4%). Across the 17 metrics below, TriSalus Life Sciences, Inc. leads on 11 and Perspective Therapeutics, Inc. on 6.

Valuation

Metric CATX TLSI Medical Devices median
P/E n/m n/m 22.18
P/S 743.38 5.61 2.70
P/B 0.94 38.63 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 167.98 5.33 2.38
Earnings yield (52.65%) (29.95%) (8.22%)
Free cash flow yield (39.86%) (9.48%) (7.80%)

Profitability

Metric CATX TLSI Medical Devices median
Gross margin 100.00% 85.79% 56.01%
Operating margin (30,619.07%) (67.68%) (15.03%)
Net margin (28,467.97%) (127.00%) (20.40%)
Free cash flow margin (29,630.07%) (51.56%) (7.24%)
Return on equity (39.50%) 889.44% (15.32%)
Return on assets (33.14%) (110.34%) (19.72%)
Return on invested capital (88.41%) 0.00% (10.33%)

Growth

Metric CATX TLSI Medical Devices median
Revenue growth (TTM) (66.88%) 25.25% 8.80%
EPS growth (last fiscal year) (13.82%) (40.46%) —
Revenue growth, 5-year CAGR (38.04%) — 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CATX TLSI Medical Devices median
Debt to equity 0.00 5.05 0.07
Current ratio 6.61 5.35 2.50
Net debt to EBITDA 1.27 (0.50) 0.49

Dividend

Metric CATX TLSI Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric CATX TLSI Medical Devices median
Market cap 285.38m 303.56m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack